SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma
G. Blumberga, L. Groes and R. Dahl
Allergy Volume 66, Issue 2, pages 178–185, February 2011
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy
A. I. Tabar, E. Arroabarren, S. Echechipía, B.E. García, S. Martin, M.J. Alvarez-Puebla
Journal of Allergy and Clinical Immunology. Vol. 127 (1) , Pages 57-63, January 2011
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
Michael Blaiss, Jennifer Maloney, Hendrik Nolte, Sandra Gawchik, Ruji Yao, David P. Skoner
Journal of Allergy and Clinical Immunology. Vol. 127(1) , Pag. 64-71. January 2011
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
Harold S. Nelson, Hendrik Nolte, Peter Creticos, Jennifer Maloney, Jiangming Wu, David I. Bernstein
Journal of Allergy and Clinical Immunology. Vol 127 (1) , Pag. 72-80, January 2011
A 5-year venom immunotherapy protocol with 50 μg maintenance dose: safety and efficacy in school children
G.N. Konstantinou, E. Manoussakis, N. Douladiris, A. Hatziioannou, S. Giavi, P. Saxoni-Papageorgiou and N.G. Papadopoulos.
Pediatric Allergy and Immunology. Published online: 16 JAN 2011
Safety of ultra-rush titration of sublingual immunotherapy in asthmatic children with tree-pollen allergy
R. Mösges, V. Graute, H. Christ, H-J. Sieber, U. Wahn and B. Niggemann
Pediatric Allergy and Immunology Volume 21, Issue 8, pages 1135–1138, December 2010
Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis
O. Pfaar, D. S. Robinson, A. Sager and R. Emuzyte
Allergy Volume 65, Issue 12, pages 1614–1621, December 2010
